Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan. 65 (1):1-11. [QxMD MEDLINE Link].
Kambham N. Crescentic Glomerulonephritis: An Update on Pauci-immune and Anti-GBM Diseases. Adv Anat Pathol. 2012 Mar. 19(2):111-24. [QxMD MEDLINE Link].
Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol. 2011 Jul 19. 7(12):697-705. [QxMD MEDLINE Link].
Ooi JD, Holdsworth SR, Kitching AR. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J Autoimmun. 2008 Nov. 31(3):295-300. [QxMD MEDLINE Link].
Olson SW, Arbogast CB, Baker TP, Owshalimpur D, Oliver DK, Abbott KC, et al. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011 Oct. 22(10):1946-52. [QxMD MEDLINE Link]. [Full Text].
Zou J, Hannier S, Cairns LS, et al. Healthy individuals have Goodpasture autoantigen-reactive T cells. J Am Soc Nephrol. 2008 Feb. 19(2):396-404. [QxMD MEDLINE Link]. [Full Text].
Wilson CB, Dixon FJ. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 1973 Feb. 3(2):74-89. [QxMD MEDLINE Link].
Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003 Mar. 63 (3):1164-77. [QxMD MEDLINE Link].
Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000 Apr. 11(4):649-57. [QxMD MEDLINE Link].
McAdoo SP, Pusey CD. Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2017 Jul 7. 12 (7):1162-1172. [QxMD MEDLINE Link].
McAdoo SP, Tanna A, Hrušková Z, Holm L, Weiner M, Arulkumaran N, et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017 May 12. [QxMD MEDLINE Link].
Syeda UA, Singer NG, Magrey M. Anti-glomerular basement membrane antibody disease treated with rituximab: A case-based review. Semin Arthritis Rheum. 2013 Jun. 42 (6):567-72. [QxMD MEDLINE Link].
Gulati K, McAdoo SP. Anti-Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018 Nov. 44 (4):651-673. [QxMD MEDLINE Link].
Biesenbach P, Kain R, Derfler K, Perkmann T, Soleiman A, Benharkou A, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption. PLoS One. 2014. 9 (7):e103568. [QxMD MEDLINE Link].
Priest N, Roseby R, Waters E, et al. Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke. Cochrane Database Syst Rev. 2008 Oct 8. CD001746. [QxMD MEDLINE Link].
Bergs L. Goodpasture syndrome. Crit Care Nurse. 2005 Oct. 25(5):50-4, 56, 57-8. [QxMD MEDLINE Link].
Bigler SA, Parry WM, Fitzwater DS, Baliga R. An 11-month-old with anti-glomerular basement membrane disease. Am J Kidney Dis. 1997 Nov. 30(5):710-2. [QxMD MEDLINE Link].
Bolton WK. Goodpasture's syndrome. Kidney Int. 1996 Nov. 50(5):1753-66. [QxMD MEDLINE Link].
Borza DB, Bondar O, Colon S, et al. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociatingautoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmunepathogenesis. J Biol Chem. 2005 Jul 22. 280(29):27147-54.
Borza DB, Hudson BG. Molecular characterization of the target antigens of anti-glomerular basementmembrane antibody disease. Springer Semin Immunopathol. 2003 May. 24(4):345-61. [QxMD MEDLINE Link].
Borza DB, Neilson EG, Hudson BG. Pathogenesis of Goodpasture syndrome: a molecular perspective. Semin Nephrol. 2003 Nov. 23(6):522-31. [QxMD MEDLINE Link].
Boven K, Miljoen HP, Van Hoeck KJ, et al. Anti-glomerular basement membrane glomerulopathy in a young child. Pediatr Nephrol. 1996 Dec. 10(6):745-7. [QxMD MEDLINE Link].
Brainwood D, Kashtan C, Gubler MC, Turner AN. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int. 1998 Mar. 53(3):762-6. [QxMD MEDLINE Link]. [Full Text].
Brito MJ, Patricio A, Rolo P, et al. Anti-glomerular basement membrane nephritis in a 5-year-old girl. Pediatr Nephrol. 1997 Feb. 11(1):80-1. [QxMD MEDLINE Link].
Burns AP, Fisher M, Li P, Pusey CD, Rees AJ. Molecular analysis of HLA class II genes in Goodpasture's disease. QJM. 1995 Feb. 88(2):93-100. [QxMD MEDLINE Link].
Cairns LS, Phelps RG, Bowie L, Hall AM, Saweirs WW, Rees AJ. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol. 2003 Nov. 14(11):2801-12. [QxMD MEDLINE Link]. [Full Text].
Cole BR, Salinas-Madrigal L. Crescentic glomerulonephritis. Pediatric Nephrology. 4th ed. Baltimore, MD: Lippincott, Williams and Wilkins; 1999. 680-6.
Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med. 2004 Sep. 25(3):583-92, vii.
Dean EG, Wilson GR, Li M, et al. Experimental autoimmune Goodpasture's disease: a pathogenetic role for botheffector cells and antibody in injury. Kidney Int. 2005 Feb. 67(2):566-75. [QxMD MEDLINE Link].
Derk CT, Jimenez SA. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemicsclerosis: report and review of the literature. J Rheumatol. 2003 Jul. 30(7):1616-20. [QxMD MEDLINE Link].
Fonck C, Loute G, Cosyns JP, Pirson Y. Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval. Am J Kidney Dis. 1998 Aug. 32(2):323-7. [QxMD MEDLINE Link].
Heeringa P, Schreiber A, Falk RJ, Jeannette JC. Pathogenesis of pulmonary vasculitis. Semin Respir Crit Care Med. 2004 Oct. 25(5):465-74. [QxMD MEDLINE Link].
Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994 Sep. 46(3):823-9. [QxMD MEDLINE Link].
Hochegger K, Wolf D, Rosenkranz AR. CD4CD25 regulatory T cells: a new treatment option in glomerulonephritis. Kidney Int. 2005 Oct. 68(4):1898-9. [QxMD MEDLINE Link].
Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003 Jun 19. 348(25):2543-56. [QxMD MEDLINE Link].
Jara LJ, Vera-Lastra O, Calleja MC. Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Rheumatol Rep. 2003 Apr. 5(2):107-15. [QxMD MEDLINE Link].
Kalluri R, Wilson CB, Weber M, et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol. 1995 Oct. 6(4):1178-85. [QxMD MEDLINE Link].
Kitching AR, Holdsworth SR, Tipping PG. Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response?. Histol Histopathol. 2000 Jul. 15(3):993-1003. [QxMD MEDLINE Link].
Kotanko P, Pusey CD, Levy JB. Recurrent glomerulonephritis following renal transplantation. Transplantation. 1997 Apr 27. 63(8):1045-52. [QxMD MEDLINE Link].
Laczika K, Knapp S, Derfler K, Soleiman A, Horl WH, Druml W. Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis. 2000 Aug. 36(2):392-5. [QxMD MEDLINE Link].
Little MA, Pusey CD. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol. 2004 Nov-Dec. 17 Suppl 8:S10-9.
Lou YH. Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease?. Arch Immunol Ther Exp (Warsz). 2004 Mar-Apr. 52(2):96-103. [QxMD MEDLINE Link].
Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal diseases [editorial]. J Am Soc Nephrol. 1996 Mar. 7(3):367-86. [QxMD MEDLINE Link].
Meisels IS, Stillman IE, Kuhlik AB. Anti-glomerular basement membrane disease and dual positivity for antineutrophil cytoplasmic antibody in a patient with membranous nephropathy. Am J Kidney Dis. 1998 Oct. 32(4):646-8. [QxMD MEDLINE Link].
Merkel F, Kalluri R, Marx M, et al. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int. 1996 Apr. 49(4):1127-33. [QxMD MEDLINE Link].
Netzer KO, Merkel F, Weber M. Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant? [editorial]. Nephrol Dial Transplant. 1998 Jun. 13(6):1346-8. [QxMD MEDLINE Link].
Phelps RG, Jones V, Turner AN, Rees AJ. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol. 2000 Aug. 12(8):1135-43. [QxMD MEDLINE Link].
Phelps RG, Jones V, Turner AN, Rees AJ. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol. 2000 Aug. 12(8):1135-43. [QxMD MEDLINE Link]. [Full Text].
Phelps RG, Rees AJ. The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. Kidney Int. 1999 Nov. 56(5):1638-53. [QxMD MEDLINE Link].
Reynolds J, Khan SB, Allen AR, et al. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int. 2004 Oct. 66(4):1444-52. [QxMD MEDLINE Link].
Reynolds J, Norgan VA, Bhambra U, et al. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatmentof experimental autoimmune glomerulonephritis. J Am Soc Nephrol. 2002 Feb. 13(2):359-69. [QxMD MEDLINE Link].
Reynolds J, Tam FW, Chandraker A. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest. 2000 Mar. 105(5):643-51. [QxMD MEDLINE Link].
Salama AD, Chaudhry AN, Holthaus KA, et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int. 2003 Nov. 64(5):1685-94. [QxMD MEDLINE Link].
Salama AD, Chaudhry AN, Holthaus KA, Mosley K, Kalluri R, Sayegh MH. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int. 2003 Nov. 64(5):1685-94. [QxMD MEDLINE Link]. [Full Text].
Salama AD, Chaudhry AN, Ryan JJ, et al. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol. 2001 Sep. 12(9):1908-15. [QxMD MEDLINE Link].
Salama AD, Chaudhry AN, Ryan JJ, et al. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol. 2001 Sep. 12(9):1908-15. [QxMD MEDLINE Link]. [Full Text].
Salama AD, Pusey CD. Immunology of anti-glomerular basement membrane disease. Curr Opin Nephrol Hypertens. 2002 May. 11(3):279-86. [QxMD MEDLINE Link].
Shah MK, Hugghins SY. Characteristics and outcomes of patients with Goodpasture's syndrome. South Med J. 2002 Dec. 95(12):1411-8. [QxMD MEDLINE Link].
Srivastava A, Rao GK, Segal PE, Shah M, Geetha D. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Clin Rheumatol. 2013 Sep. 32(9):1317-22. [QxMD MEDLINE Link].
Turner AN. Antibodies: still important in anti-GBM disease. Nephron Clin Pract. 2003. 94(3):c51-2. [QxMD MEDLINE Link].
Verburgh CA, Bruijn JA, Daha MR, van Es LA. Sequential development of anti-GBM nephritis and ANCA-associated Pauci- immune glomerulonephritis. Am J Kidney Dis. 1999 Aug. 34(2):344-8. [QxMD MEDLINE Link].
Wang XP, Fogo AB, Colon S, Giannico G, Abul-Ezz SR, Miner JH. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J Am Soc Nephrol. 2005 Dec. 16(12):3563-71. [QxMD MEDLINE Link]. [Full Text].
Wolf D, Hochegger K, Wolf AM, et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol. 2005 May. 16(5):1360-70. [QxMD MEDLINE Link].
Wong D, Phelps RG, Turner AN. The Goodpasture antigen is expressed in the human thymus. Kidney Int. 2001 Nov. 60(5):1777-83. [QxMD MEDLINE Link].
Xenocostas A, Jothy S, Collins B, et al. Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis. 1999 Jan. 33(1):128-32. [QxMD MEDLINE Link].
Yamaguchi H, Shirakami A, Haku T, Taoka T, Nakanishi Y, Inai T, et al. Pulmonary-Renal Syndrome with Negative ANCAs and Anti-GBM Antibody. Case Rep Nephrol. 2013. 2013:434531. [QxMD MEDLINE Link]. [Full Text].
Yang R, Cui Z, Hellmark T, Segelmark M, Zhao MH, Wang HY. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol. 2007 Aug. 124(2):207-12. [QxMD MEDLINE Link]. [Full Text].
Yoshioka K, Iseki T, Okada M, Morimoto Y, Eryu N, Maki S. Identification of Goodpasture antigens in human alveolar basement membrane. Clin Exp Immunol. 1988 Dec. 74(3):419-24. [QxMD MEDLINE Link].
Zou J, Henderson L, Thomas V, Swan P, Turner AN, Phelps RG. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes. J Am Soc Nephrol. 2007 Mar. 18(3):771-9. [QxMD MEDLINE Link]. [Full Text].
Canney M, O'Hara PV, McEvoy CM, Medani S, Connaughton DM, Abdalla AA, et al. Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2016 Aug 8. 11 (8):1392-9. [QxMD MEDLINE Link].
Reich EP, Sherwin RS, Kanagawa O, Janeway CA Jr. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature. 1989 Sep 28. 341 (6240):326-8. [QxMD MEDLINE Link].
Canney M, O'Hara PV, McEvoy CM, Medani S, Connaughton DM, Abdalla AA, et al. Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2016 Aug 8. 11 (8):1392-9. [QxMD MEDLINE Link].